Livforsakringsbolaget Skandia’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
VPM
VCM
Livforsakringsbolaget Skandia's EXEL Position: Q1 2026 in Review
Livforsakringsbolaget Skandia reduced its Exelixis (EXEL) stake by 17% in Q1 2026, selling an estimated $2.16M and leaving 241,103 shares worth $15.6M. The position accounts for 0.6% of the portfolio, ranked #41.
Livforsakringsbolaget Skandia first reported a position in EXEL in Q2 2025 and has held it in 4 quarters since. The position peaked at $19.6M in Q4 2025. 697 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.
- Livforsakringsbolaget Skandia held 241,103 shares of Exelixis worth $15.6M as of Q1 2026.
- Livforsakringsbolaget Skandia sold 50,247 Exelixis shares in Q1 2026, an estimated $2.16M.
- Exelixis made up 0.6% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #41 holding.
- Livforsakringsbolaget Skandia first reported a position in Exelixis in Q2 2025 and has held it in 4 quarters since.
- Livforsakringsbolaget Skandia's Exelixis position peaked at $19.6M in Q4 2025.
- 697 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.
Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.